Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
US Department of Justice
Queensland Health
Express Scripts

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,225,284

« Back to Dashboard

Summary for Patent: 6,225,284

Title: Somatostatin peptides
Abstract:Somatostain analogues comprising the amino acid sequence of the formula (I): -(D/L)Trp-Lys-X.sub.1 -X.sub.2, wherein X.sub.1 is a substituted Thr, Ser, Tyr, Glu or Cys residue and X.sub.2 is an .alpha.-amino acid having an aromatic residue on the C.sub..alpha. side chain, or an amino acid unit selected from Dab, Dpr, Dpm, His (Bzl)HyPro, thienyl-Ala, cyclohexyl-Ala and t.-butyl-Ala, the residue Lys of said sequence corresponding to the residue Lys.sup.9 of the native somatostatin-14, in free form, in salt form or complexed with a detectable element have interesting pharmacological properties.
Inventor(s): Albert; Rainer (Basel, CH), Bauer; Wilfried (Lampenberg, CH), Bruns; Christian (Freiburg, DE), Chandramouli; Nagarajan (Morristown, NJ), Lewis; Ian (Riehen, CH), Weckbecker; Gisbert (Biel-Benken, CH)
Assignee: Novartis AG (Basle, CH)
Application Number:08/981,426
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 6,225,284

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9513224Jun 29, 1995
United Kingdom9600429Jan 10, 1996
PCT Information
PCT FiledJune 28, 1996PCT Application Number:PCT/EP96/02840
PCT Publication Date:January 16, 1997PCT Publication Number: WO97/01579

International Patent Family for Patent: 6,225,284

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China1189166► Subscribe
China1156492► Subscribe
Colombia4700528► Subscribe
Czech Republic9704196► Subscribe
Czech Republic297381► Subscribe
Germany69617687► Subscribe
Denmark0835263► Subscribe
European Patent Office0835263► Subscribe
Spain2169251► Subscribe
United Kingdom9513224► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: